Medistep Healthcare Ltd. is launching its IPO to fund capital expenditure, working capital requirements, and general corporate purposes. The IPO opens on August 8, 2025 and closes on August 12, 2025. Shares are proposed to be listed on the NSE SME platform.
Key IPO Details
Particulars | Details |
---|---|
IPO Open Date | August 8, 2025 |
IPO Close Date | August 12, 2025 |
Listing Date | August 18, 2025 |
Face Value | ₹10 per equity share |
Price Band | ₹43 per share |
Issue Size | Approx. ₹16.10 Crores |
Fresh Issue | Approx. ₹16.10 Crores |
Offer for Sale | – |
Lot Size | 3,000 shares |
Issue Type | Fixed Price Issue |
IPO Listing | NSE SME |
Retail Quota | Up to 50% |
NII (HNI) Quota | Up to 50% |
Market Lot Information
Category | Lot Size | Shares | Amount (₹) |
---|---|---|---|
Retail Minimum | 2 | 6,000 | 2,58,000 |
Retail Maximum | 2 | 6,000 | 2,58,000 |
S-HNI Minimum | 3 | 9,000 | 3,87,000 |
Important IPO Dates
Event | Date |
---|---|
IPO Opening | August 8, 2025 |
IPO Closing | August 12, 2025 |
Basis of Allotment | August 13, 2025 |
Refund Initiation | August 14, 2025 |
Demat Credit | August 14, 2025 |
Listing Date | August 18, 2025 |
Promoters
- Girdhari Lal Prajapat
- Dabhi Vipul Gobarbhai
- Prajapati Hetalben Girdharilal
About the Company
Medistep Healthcare Limited is a leading pharmaceutical company engaged in trading and manufacturing pharmaceutical products, intimate care and hygiene products, surgical products, and nutraceuticals. Incorporated on June 05, 2023, the company is known for its DRYSTEP sanitary pads and VITASTEP Z energy powders. It has expanded its business by acquiring M/s MG Pharma, and aims to become a global leader offering affordable healthcare solutions. Its strengths include experienced promoters and management, product innovation, and focus on regulatory compliance.
Financial Performance
Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | Profit After Tax (₹ Cr) | Assets (₹ Cr) |
---|---|---|---|---|
2022 | 7.62 | 7.27 | 0.19 | 7.10 |
2023 | 27.74 | 26.31 | 0.92 | 14.66 |
2024 | 31.63 | 27.66 | 2.91 | 14.96 |
June 2024 | 11.25 | 9.86 | 1.02 | 24.02 |
Key Financial Ratios (FY2024)
KPI | Value |
---|---|
ROE | 52.14% |
ROCE | 69.15% |
EBITDA Margin | 11.62% |
PAT Margin | 8.52% |
Debt to Equity Ratio | 0.03 |
EPS (Basic) | ₹19.96 |
P/E Ratio | N/A |
RoNW | 28.46% |
Net Asset Value (NAV) | ₹80.11 |
Peer Group Comparison
Company | EPS | PE Ratio | RoNW (%) | NAV | Income |
---|---|---|---|---|---|
Fabino Enterprises Limited | 0.23 | 135 | 1.15% | 19.80 | 0.05 Cr. |
Achyut Healthcare Limited | 0.34 | 10.08 | 2.53% | 18.28 | 0.57 Cr. |
Purpose of the IPO
- Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
- Working capital requirements
- General corporate purpose
Registrar & Contact Details
Registrar:
Cameo Corporate Services Limited
Phone: +91-44-28460390
Email: ipo@cameoindia.com
Website: https://ipo.cameoindia.com/
Lead Manager:
Fast Track Finsec Pvt Ltd
Company Address:
Medistep Healthcare Ltd.
05, S. No-245/B, Plot-19, T.P.S. 56,
Free Way Trade Center, Nr.A-One Hotel N.H.-8
Narol Gam, Narol Daskroi,
Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/
Reviews
Brokerage and research house reviews for Medistep Healthcare IPO are awaited.
Related posts:









